Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Before you order that cocktail, here is what you need to know about safety, side effects, and your results
MedicalDaily Evidence Check Study type: Phase 3 randomized controlled trial (ATTAIN program) Participants: Adults with obesity or overweight with at least one weight-related comorbidity Approval date: April 1, 2026 What it found: Average weight loss of approximately 12.4% (about 27 lbs) at highest dose over 72 weeks What it did not prove: That it matches injectable GLP-1 efficacy
The glass chamber/vial containing the medication is framed & is visibly held within the pen's framework
The commercial invoice should list the chemical name of the peptide, the CAS number for retatrutide (2381089-83-2), the quantity in precise weight, the total declared value, and a clear statement of research-use intent
The supply is beginning to stabilize, but certain doses may still be limited or sell out quicklyespecially in high-demand areas
US$ 23.13
US$ 27.61
US$ 22.92
US$ 25.33
